| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |